-transparent.png){kind=logo}
A case of carbamazepine-induced thrombocytopenia is reported. The patient, a 38-year-old female, developed thrombocytopenia 10 days after receiving 400 mg carbamazepine daily. The presence of an anti-IgG carbamazepine-dependent platelet-reactive antibody was documented. Using flow cytometry, the drug-induced antibody was detected at a drug concentration as low as 10(-6) M.
Related Publications
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
January 1982,
Acta haematologica,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
July 1972,
Ugeskrift for laeger,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
June 1968,
The Medical letter on drugs and therapeutics,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
May 1999,
Annales francaises d'anesthesie et de reanimation,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
February 1982,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
March 1981,
Ugeskrift for laeger,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
October 1992,
Nederlands tijdschrift voor geneeskunde,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
September 2017,
Journal of clinical and diagnostic research : JCDR,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
August 1990,
Journal of clinical psychopharmacology,
Y Shechter, and
B Brenner, and
E Klein, and
I Tatarsky
March 2012,
Blood cells, molecules & diseases,
